Cipla, a company in the Pharmaceuticals industry, reported revenue of ₹7,404 crore and net profit of ₹852 crore for the September 2026 quarter.
Cipla (NSE: CIPLA) closed at ₹1,415.00 on 20 Nov 2026, down 7.5% over the past year. Its market capitalisation is ₹1,14,316 crore and it trades at 36.8 times earnings.
Incorporated in 1935, Cipla Ltd is in the business of manufacturing, developing, and marketing a wide range of branded and generic formulations and APIs
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.